Results 121 to 130 of about 38,460 (214)

Novel drug approval by the FDA: Ekterly (Sebetralstat), oral plasma kallikrein inhibitor for treating acute attacks of hereditary angioedema. [PDF]

Ann Med Surg (Lond)
Gulalai, Miraj SA, Mahato RK.
europepmc   +1 more source

Long non-coding RNA KCNQ1OT1 promotes ovarian cancer cell malignant characteristics by targeting the miR-140-5p/KLK10 axis. [PDF]

Exp Ther Med
Duan R, Tao Z, Tao S, Yang A, Yang X, Li C, Zhu X, Zhang K, Li Z, Tao S.   +9 more
europepmc   +1 more source

Kallikrein [PDF]

, 2019
openaire   +1 more source

Exploring the role of C1-inhibitor in thrombotic diseases. [PDF]

Blood Adv
Hansen JB.
europepmc   +1 more source

Perioperative anesthesia management of high-molecular-weight kininogen deficiency: a case report and literature review. [PDF]

Front Med (Lausanne)
Jiang T, Song G, Chen Y, Zhang L, Xu Y.
europepmc   +1 more source

The multifaceted role of kallistatin in human diseases: mechanistic insights and translational potential. [PDF]

Front Cardiovasc Med
Yu M, Feng Y, Wu Z, Li S.
europepmc   +1 more source

Recent Investigations on Pathogenesis, Biomarkers, Epigenetics, and Emerging Therapeutic Strategies to Modulate Multiple Signaling Pathways in Diabetic Retinopathy. [PDF]

J Ophthalmol
Huang Z, Wei J, Yang D.
europepmc   +1 more source

Delayed post-operative bradykinin-mediated angioedema: A silent airway threat and role of tranexamic acid. [PDF]

Indian J Anaesth
Madoo N, Balavenkatasubramanian J, Gurumoorthi P.   +2 more
europepmc   +1 more source

Lisinopril-Induced Angioedema Triggered by Tattoo Cellulitis and Acute Kidney Injury: A Case Report. [PDF]

Cureus
Zedan M, Howard S, Foryt P, Aroriode T.
europepmc   +1 more source

Therapeutic Advances in Hereditary Angioedema: A Focus on Present and Future Options. [PDF]

Adv Ther
Uminski K, Goodyear D, Betschel S.
europepmc   +1 more source